Cancer diagnosis stands at the forefront of ongoing research efforts, propelled by advancements in technology and understanding of the disease. From innovative imaging techniques like PET scans to the revolutionary application of artificial intelligence in pathology, the landscape of cancer diagnosis is rapidly evolving. Liquid biopsies, capable of detecting tumor DNA fragments circulating in bodily fluids, offer non-invasive alternatives to traditional tissue biopsies, enabling earlier detection and personalized treatment approaches. Additionally, emerging biomarkers and molecular profiling techniques provide deeper insights into tumor behavior, aiding in more accurate prognoses and treatment selection. As research progresses, the quest for minimally invasive, highly sensitive diagnostic tools continues, promising improved outcomes and enhanced precision in the fight against cancer.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States